Article Details
Retrieved on: 2025-04-14 20:26:33
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The FDA has granted Fast Track designation to VERVE-102 for the treatment of patients with hyperlipidemia and high lifetime cardiovascular risk to ...
Article found on: www.clinicaladvisor.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here